Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

Coronavirus disease of 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly the world over. The disease was declared “pandemic” by the World Health Organization. An approved therapy for patients with COVID-19 has yet to emerge; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Talasaz, Azita Hajhossein, Kakavand, Hessam, Van Tassell, Benjamin, Aghakouchakzadeh, Maryam, Sadeghipour, Parham, Dunn, Steven, Geraiely, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360896/
https://www.ncbi.nlm.nih.gov/pubmed/32671601
http://dx.doi.org/10.1007/s10557-020-07037-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360896/
https://www.ncbi.nlm.nih.gov/pubmed/32671601
http://dx.doi.org/10.1007/s10557-020-07037-2

Ejemplares similares